Iron(II) fumarate
Appearance
(Redirected from ATC code B03AA02)
Names | |
---|---|
IUPAC name
Iron(2+) (2E)-but-2-enedioate
| |
Other names
Ferrous fumarate; Feostat
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.004.953 |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C4H2FeO4 | |
Molar mass | 169.901 g·mol−1 |
Appearance | reddish-brown powder |
Odor | odorless |
Density | 2.435 g/cm3 (20 °C) |
Melting point | 280 °C (536 °F; 553 K) |
slightly soluble | |
Pharmacology | |
B03AA02 (WHO) | |
Hazards | |
NFPA 704 (fire diamond) | |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
3850 mg/kg (oral, rat) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Iron(II) fumarate, also known as ferrous fumarate, is the iron(II) salt of fumaric acid, occurring as a reddish-orange powder, used to supplement iron intake. It has the chemical formula C4H2FeO4. Pure ferrous fumarate has an iron content of 32.87%, therefore one tablet of 300 mg iron fumarate will contain 98.6 mg of iron (548% Daily Value based on 18 mg RDI).
Iron supplement
[edit]Ferrous fumarate is often taken orally as an iron supplement to treat or prevent iron deficiency anemia.[1] Mixtures of ferrous fumarate and potassium iodate, "double fortified salt", are used to address both iron and iodine deficiencies.[2]
See also
[edit]References
[edit]- ^ Santiago, Palacios (2012-05-02). "Ferrous versus Ferric Oral Iron Formulations for the Treatment of Iron Deficiency: A Clinical Overview". The Scientific World Journal. 2012: e846824. doi:10.1100/2012/846824. ISSN 2356-6140. PMC 3354642. PMID 22654638.
- ^ Diosady, Levente L.; Mannar, M.G. Venkatesh; Krishnaswamy, Kiruba (2019). "Improving the lives of millions through new double fortification of salt technology". Maternal & Child Nutrition. 15 (Suppl 3): e12773. doi:10.1111/mcn.12773. PMC 6594086. PMID 31148400.